<DOC>
	<DOCNO>NCT01319045</DOCNO>
	<brief_summary>Pulmonary arterial hypertension ( PAH ) , high blood pressure lung , common patient congenital heart disease . Historically patient suffer significant morbidity mortality due lack effective therapy . More recently , advanced therapy target mechanisms underlying development progression PAH introduce clinical care . Oral , intravenous , subcutaneous , inhaled therapy available treatment PAH . Patients PAH first treat oral agent ( include sildenafil bosentan ) . However , agent fail achieve desire effect patient , intravenous inhaled therapy may initiate . Combination therapy multiple agent common routine clinical care . However , efficacious therapeutic regimen yet delineate . The present study seek evaluate efficacy one specific regimen : iloprost , inhale prostacyclin derivative , use combination oral therapy ( sildenafil and/or bosentan ) . Iloprost approve FDA use patient population . Adults PAH already receive oral therapy invite participate study . Iloprost add current therapeutic regimen period three month , pre- post-treatment assessment . These include cardiopulmonary exercise test , BNP ( blood test ) , six minute walk distance , quality life questionnaire .</brief_summary>
	<brief_title>Iloprost Treatment Pulmonary Hypertension Adults With Congenital Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Eisenmenger Complex</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<mesh_term>Tezosentan</mesh_term>
	<criteria>Age great equal 18 year old Congenital heart disease pulmonary arterial hypertension cyanosis ( rest oxygen saturation &lt; 90 % room air ) Stable oral therapy ( PDE5 inhibitor and/or endothelin blockade ) least three month Age &lt; 18 year old Current intravenous subcutaneous prostacyclin therapy Resting Systemic Hypotension ( Systolic blood pressure &lt; 85 mmHg ) Women pregnant may become pregnant ( unwilling utilize effective contraception ) , well nurse mother Inability ambulate Planned surgical procedure study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Pulmonary Arterial Hypertension</keyword>
	<keyword>Congenital Heart Disease</keyword>
	<keyword>Eisenmenger 's Syndrome</keyword>
	<keyword>Prostacyclin</keyword>
	<keyword>Iloprost</keyword>
</DOC>